Atlas Trials

Evaluation of the Clinical Trial of Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease

Clinical trial NCT07147946 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07147946
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary Disease
Start date
2025-09-01
Primary completion
2027-03-01
Enrollment
666

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.